Résumé
The toxicity of viologens can be significantly reduced by including them in tight [2]rotaxane structures alongside beta-cyclodextrin, thus turning them into candidates of pharmaceutical interest. Here, we report a synthesis pathway for a benign viologen, by capping a small beta-cyclodextrin-caged molecule, the 4,4'-bipyridine, with minimal-length presynthesized axle-stopper segments of the propyl-3-pentamethyldisiloxane type. After 90 min from the oral administration to laboratory mice, the product concentration in the bloodstream reaches a value equivalent to 0.634% of the initial dose of 800 mg.kg(-1). As compared to the nude viologen having the same structure, which proved to be lethal in doses of 40 mg.kg(-1), the product induces reversible morphological changes in the liver, kidney, lung, and cerebellum, up to a dose of 400 mg.kg(-1), with higher dosages giving rise to a chronic slow evolution.